Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07388160Not Yet Recruiting

Neuroinflammatory Biomarkers After General Anesthesia: A Comparison Study

Role: lead

NCT07369544Not ApplicableActive Not Recruiting

The Effect of Preoperative Hugging With Family Members on Preoperative Anxiety Levels and Postoperative Pain

Role: lead

NCT07376798Not ApplicableNot Yet Recruiting

Effect of Patient Position on Bupivacaine Dose Requirement and Hemodynamic Stability in Spinal Anesthesia

Role: lead

NCT07301580Not ApplicableCompleted

Prehabilitation of Breast Cancer-Related Lymphedema

Role: lead

NCT07240584Not ApplicableCompleted

Exercise Prehabilitation of Breast Cancer

Role: lead

NCT06288529Completed

EFFECT SGLT2 INHIBITORS ON CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURY

Role: lead

All 6 trials loaded